Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Fundraise is about supporting Redx Pharma's next 'critical phase' of growth, says CEO Neil Murray

Redx Pharma Plc (LON:REDX) CEO Neil Murray talks to Proactive's Andrew Scott about the company's plans to raise up to £14.9mln to develop two promising pre-clinical drug candidates

 
Meet Rainbow Rare Earths Limited, Eurasia Mining plc, Mariana Resources Ltd., Anglo Asian Mining Plc and Hannan Metals Ltd at our event, London, 09 May 2017. Register here »
Why Invest In Redx Pharma Plc? Read More Here

Register here to be notified of future Redx Pharma Plc articles
View full REDX profile

Redx Pharma Plc Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use